Category: Biopharmaceuticals
Global Biopharmaceuticals
-
Microcarriers Market Size, Trends, Analysis, and Outlook By Product (Consumables, Media and Reagents, Microcarrier Beads, Equipment, Bioreactors, Culture Vessels, Others), By Application (Biopharmaceutical Production, Vaccine Production, Therapeutic Production, Regenerative Medicine), By Cell Type (Stem Cells, Immune Cells, Others), By End-user (Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Immune Cells, Others), By End-user (Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global Microcarriers market size is poised to ... Read More
-
Biopharmaceutical Excipients Market Size, Trends, Analysis, and Outlook By Product (Solubilizes & Surfactants/Emulsifiers (Triglycerides, Esters, Others), Polyols (Mannitol, Sorbitol, Others), Carbohydrates (Sucrose, Dextrose, Starch, Others), by Region, Country, Segment, and Companies, 2024-2030
... Excipients market size is poised to register 6.17% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biopharmaceutical Excipients market across By Product ... Read More
-
Opioid-Induced Constipation Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Opioid-Induced Constipation market size is poised to register ... Read More
-
Single-Use Bioprocessing Market Size, Trends, Analysis, and Outlook By Product (Simple & Peripheral Elements (Tubing, Filters, Connectors, & Transfer Systems, Bags, Sampling Systems, Probes & Sensors, Others), Apparatus & Plants (Bioreactors, Mixing, Storage, & Filling Systems, Filtration System, Chromatography Systems, Pumps, Others), Work Equipment (Cell Culture System, Syringes, Others)), By Workflow ( Upstream Bioprocessing, Fermentation, Downstream Bioprocessing), By End-use ( Biopharmaceutical Manufacturers (CMOs & CROs, In-house Manufacturers), Academic & Clinical Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Systems, Filtration System, Chromatography Systems, Pumps, Others), Work Equipment (Cell Culture System, Syringes, Others)), By Workflow ( Upstream Bioprocessing, Fermentation, Downstream Bioprocessing), By End-use ( Biopharmaceutical Manufacturers (CMOs & CROs, In-house Manufacturers), Academic & Clinical ... Read More
-
Viral Vectors and Plasmid DNA Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Adenovirus, Retrovirus, Adeno-Associated Virus (AAV), Lentivirus, Plasmids, Others), By Manufacturing (Upstream Manufacturing (Vector Amplification & Expansion, Vector Recovery/Harvesting), Downstream Manufacturing (Purification, Fill Finish)), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Fill Finish)), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), by Region, Country, Segment, ... Read More
-
Cell and Gene Therapy Bioanalytical Testing Services Market Size, Trends, Analysis, and Outlook By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Others), By Product (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Stage Of Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Cell and Gene Therapy Bioanalytical Testing Services market size is poised to register ... Read More
-
Global Erythropoietin (EPO) Drugs Market Growth 2024-2030
... market, the Erythropoietin (EPO) Drugs is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.4% during review period. The research report highlights the growth potential of the global ... Read More
-
Generic Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Type (Simple Generics, Specialty Generics, Biosimilar), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals ... Read More
-
AAV Contract Development and Manufacturing Organizations Market Size, Trends, Analysis, and Outlook By Workflow (Upstream Processing, Downstream Processing), By Type (Adherent Culture, Suspension Culture), By Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global AAV Contract Development and Manufacturing Organizations market size is poised to register ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Related Biologics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilars
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Upstream Bioprocessing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Wound Biologics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Bioseparation Chromatography
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Third Party Logistics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilar Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biologic Therapeutic Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibody Biopharmaceuticals
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Recombinant Non-Glycosylated Protein Biosimilars
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Aseptic Sampling
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Anti-Inflammatory Biologics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Fermentation Systems
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Logistics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biopharmaceuticals
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
Research Assistance
